A previous study showed an increased frequency of PD-1+TIM-3+CD4+ and PD-1+TIM-3+CD8+ T cells in the BM of ND-AML patients, but did not establish whether it has prognostic significance [27]. The gene discussed is CD8A; the disease is acute myeloid leukemia.